Circulating and dietary trans fatty acids and incident type 2 diabetes in older adults: The cardiovascular health study

Diabetes Care

Volumn 38, Issue 6, 2015, Pages 1099-1107

  Wang, Qianyi ^a   Imamura, Fumiaki ^b   Ma, Wenjie ^a   Wang, Molin ^a   Lemaitre, Rozenn N ^c   King, Irena B ^d   Song, Xiaoling ^e   Biggs, Mary L ^f   Delaney, Joseph A ^f   Mukamal, Kenneth J ^g   Djousse, Luc ^h,i   Siscovick, David S ^j   Mozaffarian, Dariush ^a,k  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^e Fred Hutchinson Cancer Research Center   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

^g BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^h BRIGHAM AND WOMEN S HOSPITAL   (United States)

ⁱ VETERANS AFFAIRS MEDICAL CENTER   (United States)

^j NEW YORK ACADEMY OF MEDICINE   (United States)

^k TUFTS UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CIS FATTY ACID; FATTY ACID DERIVATIVE; GLUCOSE; TRANS FATTY ACID; EDIBLE OIL; PHOSPHOLIPID;

AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HABIT; HUMAN; INCIDENCE; LIPOGENESIS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITIONAL ASSESSMENT; PHOSPHOLIPID BLOOD LEVEL; POPULATION RESEARCH; PREVALENCE; PROSPECTIVE STUDY; QUESTIONNAIRE; RISK ASSESSMENT; BLOOD; CLINICAL TRIAL; DIABETIC ANGIOPATHY; EPIDEMIOLOGY; FEEDING BEHAVIOR; METABOLISM; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL;

AGED; BIOMARKERS; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIETARY FATS, UNSATURATED; EPIDEMIOLOGIC METHODS; FEMALE; FOOD HABITS; HUMANS; MALE; PHOSPHOLIPIDS; TRANS FATTY ACIDS;

EID: 84962420919     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc14-2101     Document Type: Article

References (41)

1. Mozaffarian D, Willett WC. Trans fatty acids and cardiovascular risk: a unique cardiometabolic imprint? Curr Atheroscler Rep 2007;9:486-493.
2. Ascherio A, Katan MB, Zock PL, Stampfer MJ, Willett WC. Trans fatty acids and coronary heart disease. N Engl J Med 1999;340:1994-1998.
3. Lemaitre RN, King IB, Mozaffarian D, et al. Plasma phospholipid trans fatty acids, fatal ischemic heart disease, and sudden cardiac death in older adults: The cardiovascular health study. Circulation 2006;114:209-215.
4. Ibrahim A, Natrajan S, Ghafoorunissa R. Dietary trans-fatty acids alter adipocyte plasma membrane fatty acid composition and insulin sensitivity in rats. Metabolism 2005;54:240-246.
5. Saravanan N, Haseeb A, Ehtesham NZ, Ghafoorunissa. Differential effects of dietary saturated and trans-fatty acids on expression of genes associated with insulin sensitivity in rat adipose tissue. Eur J Endocrinol 2005;153: 159-165.
6. Huang Z, Wang B, Pace RD, Yoon S. Trans fat intake lowers total cholesterol and high-density lipoprotein cholesterol levels without changing insulin sensitivity index in Wistar rats. Nutr Res 2009;29:206-212.
7. Bernal CA, Rovira J, Colandre ME, Cusso R, Cadefau JA. Effects of dietary cis and trans unsaturated and saturated fatty acids on the glucose metabolites and enzymes of rats. Br J Nutr 2006;95:947-954.
8. Shao F, Ford DA. Elaidic acid increases hepatic lipogenesis by mediating sterol regulatory element binding protein-1c activity in HuH-7 cells. Lipids 2014;49:403-413.
9. Obara N, Fukushima K, Ueno Y, et al. Possible involvement and the mechanisms of excess trans-fatty acid consumption in severe NAFLD in mice. J Hepatol 2010;53:326-334.
10. Rector RS, Thyfault JP, Wei Y, Ibdah JA. Nonalcoholic fatty liver disease and the metabolic syndrome: an update. World J Gastroenterol 2008;14:185-192.
11. Tardy AL, Lambert-Porcheron S, Malpuech- Brugere C, et al. Dairy and industrial sources of trans fat do not impair peripheral insulin sensitivity in overweight women. Am J Clin Nutr 2009;90:88-94.
12. Lovejoy JC, Smith SR, Champagne CM, et al. Effects of diets enriched in saturated (palmitic), monounsaturated (oleic), or trans (elaidic) fatty acids on insulin sensitivity and substrate oxidation in healthy adults. Diabetes Care 2002;25:1283- 1288.
13. Louheranta AM, Turpeinen AK, Vidgren HM, Schwab US, Uusitupa MI. A high-trans fatty acid diet and insulin sensitivity in young healthy women. Metabolism 1999;48:870-875.
14. Christiansen E, Schnider S, Palmvig B, Tauber-Lassen E, Pedersen O. Intake of a diet high in trans monounsaturated fatty acids or saturated fatty acids. Effects on postprandial insulinemia and glycemia in obese patients with NIDDM. Diabetes Care 1997; 20:881-887.
15. Vega-Lopez S, Ausman LM, Jalbert SM, Erkkila AT, Lichtenstein AH. Palm and partially hydrogenated soybean oils adversely alter lipoprotein profiles compared with soybean and canola oils in moderately hyperlipidemic subjects. Am J Clin Nutr 2006;84:54-62.
16. Salmeron J, Hu FB, Manson JE, et al. Dietary fat intake and risk of type 2 diabetes in women. Am J Clin Nutr 2001;73:1019-1026.
17. van Dam RM, Willett WC, Rimm EB, Stampfer MJ, Hu FB. Dietary fat and meat intake in relation to risk of type 2 diabetes in men. Diabetes Care 2002;25:417-424.
18. Meyer KA, Kushi LH, Jacobs DR Jr, Folsom AR. Dietary fat and incidence of type 2 diabetes in older Iowa women. Diabetes Care 2001;24: 1528-1535.
19. Lemaitre RN, King IB, Raghunathan TE, et al. Cell membrane trans-fatty acids and the risk of primary cardiac arrest. Circulation 2002;105: 697-701.
20. Wang Q, Imamura F, Lemaitre RN, et al. Plasma phospholipid trans-fatty acids levels, cardiovascular diseases, and total mortality: The cardiovascular health study. J Am Heart Assoc 2014;3.
21. Mozaffarian D, Cao H, King IB, et al. Transpalmitoleic acid, metabolic risk factors, andnew-onset diabetes in U.S. adults: a cohort study. Ann Intern Med 2010;153:790-799.
22. Mozaffarian D, de Oliveira Otto MC, Lemaitre RN, et al. trans-Palmitoleic acid, other dairy fat biomarkers, and incident diabetes: The Multi-Ethnic Study of Atherosclerosis (MESA). Am J Clin Nutr 2013;97:854-861.
23. Fried LP, Borhani NO, Enright P, et al. The Cardiovascular Health Study: design and rationale. Ann Epidemiol 1991;1:263-276.
24. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R; Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360:1903-1913.
25. Lewington S, Whitlock G, Clarke R, et al.; Prospective Studies Collaboration. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55, 000 vascular deaths. Lancet 2007;370:1829-1839.
26. Kumanyika SK, Tell GS, Shemanski L, Martel J, Chinchilli VM. Dietary assessment using a picturesort approach. Am J Clin Nutr 1997;65(Suppl.): 1123S-1129S.
27. Feskanich D, Rimm EB, Giovannucci EL, et al. Reproducibility and validity of food intake measurements from a semiquantitative food frequency questionnaire. J Am Diet Assoc 1993;93:790-796.
28. Willett WC, Stampfer MJ, Manson JE, et al. Intake of trans fatty acids and risk of coronary heart disease among women. Lancet 1993;341: 581-585.
29. Imamura F, Mukamal KJ, Meigs JB, et al. Risk factors for type 2 diabetes mellitus preceded by b-cell dysfunction, insulin resistance, or both in older adults: The Cardiovascular Health Study. Am J Epidemiol 2013;177:1418-1429.
30. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
31. Nettleton JA, Hivert MF, Lemaitre RN, et al. Meta-analysis investigating associations between healthy diet and fasting glucose and insulin levels and modification by loci associated with glucose homeostasis in data from 15 cohorts. Am J Epidemiol 2013;177:103-115.
32. Micha R, King IB, Lemaitre RN, et al. Food sources of individual plasma phospholipid trans fatty acid isomers: The Cardiovascular Health Study. Am J Clin Nutr 2010;91:883-893.
33. Willson TM, Lambert MH, Kliewer SA. Peroxisome proliferator-activated receptor gamma and metabolic disease. Annu Rev Biochem 2001; 70:341-367.
34. Goldberg IJ. Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis. J Lipid Res 1996;37:693-707.
35. Kavanagh K, Jones KL, Sawyer J, et al. Trans fat diet induces abdominal obesity and changes in insulin sensitivity in monkeys. Obesity (Silver Spring) 2007;15:1675-1684.
36. Forouhi NG, Koulman A, Sharp SJ, et al. Differences in the prospective association between individual plasma phospholipid saturated fatty acids and incident type 2 diabetes: The EPICInterAct case-cohort study. Lancet Diabetes Endocrinol 2014;2:810-818.
37. Ameer F, Scandiuzzi L, Hasnain S, Kalbacher H, Zaidi N. De novo lipogenesis in health and disease. Metabolism 2014;63:895-902.
38. Ma W, Wu JH, Wang Q, et al. Prospective association of fatty acids in the de novo lipogenesis pathway with risk of type 2 diabetes: The Cardiovascular Health Study. Am J Clin Nutr 2015;101:153-163.
39. Teubert A, Thome J, Buttner A, Richter J, Irmisch G. Elevated oleic acid serum concentrations in patients suffering from alcohol dependence. J Mol Psychiatry 2013;1:13.
40. Hu FB, Stampfer MJ, Manson JE, et al. Dietary fat intake and the risk of coronary heart disease in women. N Engl J Med 1997;337:1491-1499.
41. Oomen CM, Ocḱe MC, Feskens EJ, van Erp- Baart MA, Kok FJ, Kromhout D. Association between trans fatty acid intake and 10-year risk of coronary heart disease in the Zutphen Elderly Study: a prospective population-based study. Lancet 2001;357:746-751.